Vera Therapeutics Inc - Ordinary Shares - Class A Forecast, price target & analysts
$29.65
0.82%
today
Nasdaq,
Feb 28, 08:51 pm CET
Vera Therapeutics Inc - Ordinary Shares - Class A Target price 2025 - Analyst rating & recommendation
Powered by
Vera Therapeutics Inc - Ordinary Shares - Class A Classifications & Recommendation:
Buy
92%
Hold
8%
Vera Therapeutics Inc - Ordinary Shares - Class A Price Target
| Target Price | $65.46 |
| Price | $29.41 |
| Potential |
122.58%
register free of charge
|
| Number of Estimates | 13 |
|
13 Analysts have issued a price target Vera Therapeutics Inc - Ordinary Shares - Class A 2026 .
The average Vera Therapeutics Inc - Ordinary Shares - Class A target price is $65.46.
This is
122.58%
register free of charge
$107.00
263.82%
register free of charge
$34.00
15.61%
register free of charge
|
|
| A rating was issued by 13 analysts: 12 Analysts recommend Vera Therapeutics Inc - Ordinary Shares - Class A to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Vera Therapeutics Inc - Ordinary Shares - Class A stock has an average upside potential 2026 of
122.58%
register free of charge
|
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
Create a premium account to unlock analyst estimates.
Learn more
Powered by
Quarter
Annually
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -2.75 | -3.51 |
| 22.22% | 27.64% | |
| P/E | negative |
5 Analysts have issued a Vera Therapeutics Inc - Ordinary Shares - Class A forecast for earnings per share. The average Vera Therapeutics Inc - Ordinary Shares - Class A <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
$-3.51
Unlock
28.10%
lower
Unlock
$-3.00
9.49%
Unlock
$-4.71
71.90%
Unlock
This results in the following potential growth metrics and future valuations:
Vera Therapeutics Inc - Ordinary Shares - Class A...
Current Vera Therapeutics Inc - Ordinary Shares - Class A Upgrades & Downgrades Beta
Create a Premium account to unlock Upgrades/Downgrades.
Learn more
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Guggenheim | Locked ➜ Locked | Locked | Feb 27 2025 |
| Wolfe Research | Locked ➜ Locked | Locked | Feb 04 2025 |
| Wells Fargo | Locked ➜ Locked | Locked | Nov 21 2024 |
| Wedbush | Locked ➜ Locked | Locked | Nov 08 2024 |
| JP Morgan | Locked ➜ Locked | Locked | Nov 05 2024 |
| Guggenheim | Locked ➜ Locked | Locked | Oct 28 2024 |
| Scotiabank | Locked ➜ Locked | Locked | Oct 16 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Guggenheim: Locked ➜ Locked
|
Feb 27 2025 |
|
Locked
Wolfe Research: Locked ➜ Locked
|
Feb 04 2025 |
|
Locked
Wells Fargo: Locked ➜ Locked
|
Nov 21 2024 |
|
Locked
Wedbush: Locked ➜ Locked
|
Nov 08 2024 |
|
Locked
JP Morgan: Locked ➜ Locked
|
Nov 05 2024 |
|
Locked
Guggenheim: Locked ➜ Locked
|
Oct 28 2024 |
|
Locked
Scotiabank: Locked ➜ Locked
|
Oct 16 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
